127 related articles for article (PubMed ID: 9579603)
1. FMC7 antigen expression on normal and malignant B-cells can be predicted by expression of CD20.
Hübl W; Iturraspe J; Braylan RC
Cytometry; 1998 Apr; 34(2):71-4. PubMed ID: 9579603
[TBL] [Abstract][Full Text] [Related]
2. Pan B-cell markers are not redundant in analysis of chronic lymphocytic leukemia (CLL).
Monaghan SA; Peterson LC; James C; Marszalek L; Khoong A; Bachta DJ; Karpus WJ; Goolsby CL
Cytometry B Clin Cytom; 2003 Nov; 56(1):30-42. PubMed ID: 14582135
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic significance of CD20 and FMC7 expression in B-cell disorders.
Delgado J; Matutes E; Morilla AM; Morilla RM; Owusu-Ankomah KA; Rafiq-Mohammed F; del Giudice I; Catovsky D
Am J Clin Pathol; 2003 Nov; 120(5):754-9. PubMed ID: 14608903
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody FMC7 detects a conformational epitope on the CD20 molecule: evidence from phenotyping after rituxan therapy and transfectant cell analyses.
Serke S; Schwaner I; Yordanova M; Szczepek A; Huhn D
Cytometry; 2001 Apr; 46(2):98-104. PubMed ID: 11309819
[TBL] [Abstract][Full Text] [Related]
5. A cholesterol-dependent CD20 epitope detected by the FMC7 antibody.
Polyak MJ; Ayer LM; Szczepek AJ; Deans JP
Leukemia; 2003 Jul; 17(7):1384-9. PubMed ID: 12835728
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites.
Gervasi F; Lo Verso R; Giambanco C; Cardinale G; Tomaselli C; Pagnucco G
Ann N Y Acad Sci; 2004 Dec; 1028():457-62. PubMed ID: 15650271
[TBL] [Abstract][Full Text] [Related]
7. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases.
Chow KU; Sommerlad WD; Boehrer S; Schneider B; Seipelt G; Rummel MJ; Hoelzer D; Mitrou PS; Weidmann E
Haematologica; 2002 Jan; 87(1):33-43. PubMed ID: 11801463
[TBL] [Abstract][Full Text] [Related]
8. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
9. GM-CSF does not increase CD20 antigen expression on chronic lymphocytic leukemia lymphocytes.
Yağci M; Akar I; Sucak GT; Haznedar R
Leuk Res; 2005 Jul; 29(7):735-8. PubMed ID: 15927668
[TBL] [Abstract][Full Text] [Related]
10. Detection of subgroups of chronic B-cell leukemias by FMC7 monoclonal antibody.
Huh YO; Pugh WC; Kantarjian HM; Stass SA; Cork A; Trujillo JM; Keating MJ
Am J Clin Pathol; 1994 Mar; 101(3):283-9. PubMed ID: 8135183
[TBL] [Abstract][Full Text] [Related]
11. MY4 expression on B-lymphocyte malignancies may be associated with a more adverse prognosis.
Warzynski MJ; Otto RN; Steingart RH; White CF; Rosen MH; Hetzel PC; Flatow FA; Podgurski AE; Johnson ML
Leuk Res; 1991; 15(5):357-65. PubMed ID: 2046387
[TBL] [Abstract][Full Text] [Related]
12. Three new monoclonal antibodies that define a unique antigen associated with prolymphocytic leukemia/non-Hodgkin's lymphoma and are effectively internalized after binding to the cell surface antigen.
Okazaki M; Luo Y; Han T; Yoshida M; Seon BK
Blood; 1993 Jan; 81(1):84-94. PubMed ID: 8417805
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotyping of mature B-cell non Hodgkin lymphoma involving bone marrow and peripheral blood: critical analysis and insights gained at a tertiary care cancer hospital.
Gujral S; Polampalli SN; Badrinath Y; Kumar A; Subramanian PG; Nair R; Gupta S; Sengar M; Nair C
Leuk Lymphoma; 2009 Aug; 50(8):1290-300. PubMed ID: 19811331
[TBL] [Abstract][Full Text] [Related]
14. Blood microvesicles during chronic lymphoproliferative diseases.
Domnikova NP; Dolgikh TY; Sholenberg EV; Vorontsova EV; Goreva OB; Mel'nikova EV; Gorbachenko EA; Grishanova AY
Bull Exp Biol Med; 2013 Nov; 156(1):94-7. PubMed ID: 24319739
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of CD23 and FMC7 antigen coexistent expression in B-cell lymphoproliferative disorder subclassification.
Ahmad E; Garcia D; Davis BH
Cytometry; 2002 Feb; 50(1):1-7. PubMed ID: 11857591
[TBL] [Abstract][Full Text] [Related]
16. Holding on to the Matutes score while dropping FMC7: new opportunity from standardised approaches in multiparameter flow cytometry.
Zhu J; Raimbault A; Sourdeau E; Maillon A; Mathis S; Capron C; Lemaire P; Ronez E; Moatti H; Jondeau K; Clauser S; Bardet V
Br J Haematol; 2020 Aug; 190(4):e255-e258. PubMed ID: 32557566
[No Abstract] [Full Text] [Related]
17. Effects of cytokines on CD20 antigen expression on tumor cells from patients with chronic lymphocytic leukemia.
Venugopal P; Sivaraman S; Huang XK; Nayini J; Gregory SA; Preisler HD
Leuk Res; 2000 May; 24(5):411-5. PubMed ID: 10785263
[TBL] [Abstract][Full Text] [Related]
18. Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas.
Teeling JL; French RR; Cragg MS; van den Brakel J; Pluyter M; Huang H; Chan C; Parren PW; Hack CE; Dechant M; Valerius T; van de Winkel JG; Glennie MJ
Blood; 2004 Sep; 104(6):1793-800. PubMed ID: 15172969
[TBL] [Abstract][Full Text] [Related]
19. Human Lyb-2 homolog CD72 is a marker for progenitor B-cell leukemias.
Schwarting R; Castello R; Moldenhauer G; Pezzutto A; von Hoegen I; Ludwig WD; Parnes JR; Dörken B
Am J Hematol; 1992 Nov; 41(3):151-8. PubMed ID: 1384316
[TBL] [Abstract][Full Text] [Related]
20. Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells.
Uckun FM; Gajl-Peczalska K; Myers DE; Jaszcz W; Haissig S; Ledbetter JA
Blood; 1990 Dec; 76(12):2449-56. PubMed ID: 1702326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
